Search

Your search keyword '"García-Closas M"' showing total 256 results

Search Constraints

Start Over You searched for: Author "García-Closas M" Remove constraint Author: "García-Closas M"
256 results on '"García-Closas M"'

Search Results

1. Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium

2. Mendelian randomisation study of smoking exposure in relation to breast cancer risk

3. Mendelian randomization analyses suggest a role for cholesterol in the development of endometrial cancer

4. Common variants in breast cancer risk loci predispose to distinct tumor subtypes

5. Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses

6. Assessment of interactions between 205 breast cancer susceptibility loci and 13 established risk factors in relation to breast cancer risk, in the Breast Cancer Association Consortium

7. Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes

8. Genome-wide association study of germline variants and breast cancer-specific mortality

9. Body mass index and breast cancer survival: a Mendelian randomization analysis

10. rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk

11. Evidence that the 5p12 variant rs10941679 confers susceptibility to estrogen receptor positive breast cancer through FGF10 and MRPS30 regulation

12. RAD51B in familial breast cancer

13. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

14. Fine-scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer

15. Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis

16. Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium

18. SNP-SNP interaction analysis of NF-κB signaling pathway on breast cancer survival

19. Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium

20. Identification of novel genetic markers of breast cancer survival

21. A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium

22. Differential Misclassification and the Assessment of Gene-Environment Interactions in Case-Control Studies

23. TGFB1 and TGFBR1 polymorphic variants in relationship to bladder cancer risk and prognosis

25. Established breast cancer risk factors by clinically important tumour characteristics.

26. Prediction of non-muscle invasive bladder cancer outcomes assessed by innovative multimarker prognostic models.

27. Abstract LB-337: Synergistic effects of twelve common genetic polymorphisms and smoking habits on absolute risk of bladder cancer

31. LINE-1 methylation in leukocyte DNA, interaction with phosphatidylethanolamine N-methyltransferase variants and bladder cancer risk.

32. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

33. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.

34. Variation in NF- B Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer

35. Epidemiologic determinants of vaginal pH.

36. Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome

37. Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium

38. Risk of Ovarian Cancer and the NF- B Pathway: Genetic Association with IL1A and TNFSF10

39. Prostate Cancer Susceptibility Polymorphism rs2660753 Is Not Associated with Invasive Ovarian Cancer

40. LIN28B Polymorphisms Influence Susceptibility to Epithelial Ovarian Cancer

41. MicroRNA Processing and Binding Site Polymorphisms Are Not Replicated in the Ovarian Cancer Association Consortium

42. Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk

43. Single Nucleotide Polymorphisms in the TP53 Region and Susceptibility to Invasive Epithelial Ovarian Cancer

45. Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy

46. Association analysis identifies 65 new breast cancer risk loci

47. rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk

48. Prediction of breast cancer risk based on common genetic variants in women of East Asian ancestry

49. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

50. Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers

Catalog

Books, media, physical & digital resources